Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 12, 2026
EXPRESS: Downregulation of <i>Trpv4</i> and <i>Klf2</i> in brain microvessels is associated with the progression of neurovascular dysfunction and cognitive impairment in a model of heart failure with preserved ejection fraction
Sara M P Lambrichts, Laura van der Taelen, Irene Pastor, et al.
Journal of Clinical Pathology
|
June 24, 2018
Essential thrombocythaemia with mutation in <i>MPL</i>: clinicopathological correlation and comparison with <i>JAK</i>2V617F-mutated and <i>CALR-</i>mutated genotypes
Alberto Alvarez-Larran, Daniel Martínez, Leonor Arenillas, et al.
Blood Advances
|
October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILING
Álvaro Díaz González, Elvira Mora, Marta Garrote, et al.
British Journal of Haematology
|
August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
Alberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.
Hemasphere
|
July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
Alberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
Medicina Clinica
|
January 26, 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
Irene Pastor-Galán, Juan Carlos Hernández-Boluda, Juan-Gonzalo Correa, et al.
Leukemia
|
September 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Soledad Noya, et al.
Blood Cancer Journal
|
December 4, 2018
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
Juan Carlos Hernández-Boluda, Arturo Pereira, Irene Pastor-Galán, et al.
Hemasphere
|
April 6, 2026
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 11, 2024
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome
Rafael Hernani, Mika Aiko, Ruth Victorio, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
June 12, 2026
EXPRESS: Downregulation of <i>Trpv4</i> and <i>Klf2</i> in brain microvessels is associated with the progression of neurovascular dysfunction and cognitive impairment in a model of heart failure with preserved ejection fraction
Sara M P Lambrichts, Laura van der Taelen, Irene Pastor, et al.
Journal of Clinical Pathology
|
June 24, 2018
Essential thrombocythaemia with mutation in <i>MPL</i>: clinicopathological correlation and comparison with <i>JAK</i>2V617F-mutated and <i>CALR-</i>mutated genotypes
Alberto Alvarez-Larran, Daniel Martínez, Leonor Arenillas, et al.
Blood Advances
|
October 28, 2025
OPTICAL GENOME MAPPING IN MYELOFIBROSIS: ENHANCING PROGNOSTIC ACCURACY THROUGH HIGH-RESOLUTION GENOMIC PROFILING
Álvaro Díaz González, Elvira Mora, Marta Garrote, et al.
British Journal of Haematology
|
August 4, 2020
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
Alberto Alvarez-Larrán, Anna Angona, Marcio Andrade-Campos, et al.
Hemasphere
|
July 21, 2023
Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
Alberto Alvarez-Larrán, Beatriz Cuevas, Patricia Velez, et al.
Medicina Clinica
|
January 26, 2020
Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis
Irene Pastor-Galán, Juan Carlos Hernández-Boluda, Juan-Gonzalo Correa, et al.
Leukemia
|
September 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Soledad Noya, et al.
Blood Cancer Journal
|
December 4, 2018
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
Juan Carlos Hernández-Boluda, Arturo Pereira, Irene Pastor-Galán, et al.
Hemasphere
|
April 6, 2026
Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia
Marta Santaliestra, Marta Garrote, María Concepción Fernández-Rodríguez, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 11, 2024
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome
Rafael Hernani, Mika Aiko, Ruth Victorio, et al.
Page
of 3